| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| S646142-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $541.90 |
| Biochemical and Physiological Mechanisms | Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F , and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research[ |
|---|---|
| Storage Temp | Store at -20°C |
| Shipped In | Ice chest + Ice pads |
| Product Description | Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody comprised of monovalent camelid-derived nanobodies specific to human interleukin (IL)-17A, IL-17F , and human serum albumin VHHs. Sonelokimab has the potential for plaque-type psoriasis research IC50& Target:IL-17A|IL-17F |
| Canonical SMILES | [Sonelokimab] |
|---|
